BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29325465)

  • 1. Prevalence of positive QuantiFERON gold in-tube testing in hidradenitis suppurativa.
    Boortalary T; Misra K; McNish S; Jones D; Shanmugam VK
    J Dermatolog Treat; 2018 Sep; 29(6):637-640. PubMed ID: 29325465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
    Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D
    Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists.
    Baričević D; Popović Grle S; Morović Vergles J; Čuković Čavka S; Jakopović M; Redžepi G; Boras Z; Baričević M; Samaržija M
    Acta Clin Croat; 2017 Jun; 56(2):203-209. PubMed ID: 29485786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
    Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
    Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
    Matsumoto T; Yamazaki T
    Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
    Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
    Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection.
    Bélard E; Semb S; Ruhwald M; Werlinrud AM; Soborg B; Jensen FK; Thomsen H; Brylov A; Hetland ML; Nordgaard-Lassen I; Ravn P
    Inflamm Bowel Dis; 2011 Nov; 17(11):2340-9. PubMed ID: 21319275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QuantiFERON-TB Gold Plus Is a More Sensitive Screening Tool than QuantiFERON-TB Gold In-Tube for Latent Tuberculosis Infection among Older Adults in Long-Term Care Facilities.
    Chien JY; Chiang HT; Lu MC; Ko WC; Yu CJ; Chen YH; Hsueh PR
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29793966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
    Jeong DH; Kang J; Jung YJ; Yoo B; Lee CK; Kim YG; Hong S; Shim TS; Jo KW
    PLoS One; 2018; 13(7):e0198756. PubMed ID: 29975703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of latent tuberculosis infection among migrant farmworkers along the US-Mexico border.
    Oren E; Fiero MH; Barrett E; Anderson B; Nuῆez M; Gonzalez-Salazar F
    BMC Infect Dis; 2016 Nov; 16(1):630. PubMed ID: 27809805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.
    Sauzullo I; Mengoni F; Marocco R; Potenza C; Skroza N; Tieghi T; Lichtner M; Vullo V; Mastroianni CM
    Br J Dermatol; 2013 Nov; 169(5):1133-40. PubMed ID: 23909256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antinuclear antibodies in hidradenitis suppurativa.
    Mulani S; McNish S; Jones D; Shanmugam VK
    Int J Rheum Dis; 2018 May; 21(5):1018-1022. PubMed ID: 29878616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
    Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
    Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographics and prevalence of positive QuantiFERON-TB Gold In-Tube test in renal transplant candidates.
    Simkins J; Kraus K; Morris MI
    Transpl Infect Dis; 2016 Feb; 18(1):5-13. PubMed ID: 26534762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube assay for the detection of latent tuberculosis infection among healthcare workers in a low-incidence setting.
    Cummings KJ; Smith TS; Shogren ES; Khakoo R; Nanda S; Bunner L; Smithmyer A; Soccorsi D; Kashon ML; Mazurek GH; Friedman LN; Weissman DN
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1123-6. PubMed ID: 19803719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy.
    Saracino A; Scotto G; Fornabaio C; Martinelli D; Faleo G; Cibelli D; Tartaglia A; Di Tullio R; Fazio V; Prato R; Monno L; Angarano G
    New Microbiol; 2009 Oct; 32(4):369-76. PubMed ID: 20128443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QuantiFERON-TB Gold In-Tube test in active tuberculosis patients and healthy adults.
    Phetsuksiri B; Srisungngam S; Rudeeaneksin J; Boonchu S; Klayut W; Norrarat R; Sangkitporn S; Kasetjaroen Y
    Rev Inst Med Trop Sao Paulo; 2018 Oct; 60():e56. PubMed ID: 30365639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.